All Sauce from Weekly Sauce:

Regeneron Pharmaceuticals said Tuesday that its antibody cocktail, which is used widely to treat COVID-19 patients, may be less effective against the Omicron variant. The company noted that prior analyses suggest that its monoclonal antibody cocktail, and similar drugs, could lose effectiveness against the variant. Further research is ongoing, according to Regeneron, which added there…  read on >  read on >

U.S. cancer clinical trial participants have become more diverse in makeup, but certain groups remain underrepresented, a new study finds. It’s important to have a wide range of participants in clinical trials, to find out if treatments are safe and effective for people with different characteristics, according to the National Cancer Institute (NCI), which has…  read on >  read on >

According to new research, people with psychiatric disorders often have to deal with another trouble: Higher rates of type 2 diabetes than the general population. “Increased prevalence of type 2 diabetes among individuals with a psychiatric disorder suggests that these conditions have a shared vulnerability,” the Danish researchers said. In the study, the investigators searched…  read on >  read on >

Besides its terrible impact on mental health, postpartum depression can also bring long-term financial struggles to affected women, new research shows. “These findings highlight the importance of screening and expanding access to mental health support services for low-income pregnant and postpartum women,” said study author Slawa Rokicki, an instructor at Rutgers School of Public Health…  read on >  read on >